Definitive Contract VA69D17C0092
Award Date
2/23/17
Potential Completion Date
4/30/17
Potential Value
$3.9M
Federal Agency
Veterans Integrated Service Network 12
Awardee
Glaxosmithkline, LLC
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Research Triangle Park, NC 27709, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Glaxosmithkline, LLC, a pharmaceutical company, is for the drug RELENZA NDC # 00173-0681-22. The contract has a ceiling value of $249,900.00 and is a firm fixed price purchase order from the U.S. Department of Health and Human Services. The contract has an ultimate completion date of August 15, 2024 and was awarded on July 16, 2024. This award does not have a set-aside designation. Glaxosmithkline, a global pharmaceutical firm, frequently provides vaccines,...
This is a definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian federal agency, to Glaxosmithkline, LLC, a foreign-owned, for-profit pharmaceutical company. The contract is for the supply of RELENZA (ZANAMIVIR) ROTADISK, 5MG, an antiviral medication. The contract has a firm fixed price, with a ceiling value of $45,499,950.00, and a completion date of September 29, 2030. There is no set-aside designation for this contract. Glaxosmithkline...
The U.S. Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response awarded a $8,712,138.75 firm fixed price delivery order to Glaxosmithkline, LLC for the supply of RELENZA (ZANAMIVIR) ROTADISK. This award is not associated with a set-aside program. Glaxosmithkline is a pharmaceutical company that provides a range of products to federal agencies, including influenza vaccines, COVID-19 treatments, and other antiviral medications. This contract...
This federal contract award to Glaxosmithkline, LLC (doing business as Glaxosmithkline) is for the purchase of 7,617 courses of the antiviral medication Zanamir (Relenza) at a firm fixed price of $17.37 per course, totaling $132,307.29. The award is from the Department of Homeland Security Countering Weapons of Mass Destruction program, with delivery required by October 31, 2018. The contract does not have a set-aside designation. Glaxosmithkline is a pharmaceutical company that provides a range...
This federal contract award, identified as VA797P16C0027|VA24617F0401, was issued by the Veterans Integrated Service Network 6 (VISN 6) of the U.S. Department of Veterans Affairs to Glaxosmithkline, LLC, a pharmaceutical company, for the delivery of flu vaccines. The $76,674.00 firm fixed price contract has an ultimate completion date of October 29, 2016. Glaxosmithkline is the prime contractor for this delivery order contract, which is not designated as a set-aside. The company has received...
This is a firm fixed price delivery order contract awarded by the Department of Homeland Security to Glaxosmithkline, LLC, a foreign-owned pharmaceutical company, to procure the antiviral medication Relenza. The contract has a potential value of $367,068.00 and does not have a set-aside designation. Glaxosmithkline has provided a range of pharmaceutical goods and services to various U.S. government agencies, including vaccines, antiviral medications, and other products to support disease...
This is a federal contract award from the Defense Logistics Agency Troop Support Medical to Glaxosmithkline, LLC, a pharmaceutical company that provides vaccines, antiviral medications, and other pharmaceutical products to U.S. government agencies. The contract is for the delivery of zanamivir, an antiviral medication, with a potential value of $118,463.40. It is a firm fixed price delivery order contract, with no set-aside designation. Glaxosmithkline has received multiple federal contracts and...
This is a federal contract award from the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Glaxosmithkline, LLC, a pharmaceutical company, for the delivery of flu vaccines. The $319,475 firm fixed-price delivery order contract has an October 15, 2017 completion date and was awarded on March 30, 2017. The contract did not have a set-aside designation. Glaxosmithkline has provided a range of pharmaceutical products to U.S. government agencies through federal contracts...
This federal contract award, SPE2DP18D0010|SPE2DP18F5904, was issued by the Defense agency Medical Supply Chain to the prime contractor Glaxosmithkline, LLC, a pharmaceutical company that provides vaccines, antiviral medications, and other products to U.S. government agencies. The contract is for the delivery of the antiviral medication zanamivir, with a total ceiling value of $92,628.80 and a completion date of February 19, 2019. The contract is a firm fixed price delivery order, with no...
This contract award is for the delivery of flu vaccines to the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network 5. The prime contractor is Glaxosmithkline, LLC, doing business as Glaxosmithkline, a pharmaceutical company that provides vaccines, antivirals, and other pharmaceutical products to U.S. government agencies through federal contracts and grants. The contract is a $118,560.00 firm fixed price delivery order with a completion...